
Sign up to save your podcasts
Or


We saw the amazing performance of Pfizer and Moderna's two mRNA COVID vaccines in their RCTs. As encouraging as trial performance is, we always want to know how those numbers hold up under large-scale, real-world pragmatic conditions. Well, we now have three new pieces of information on that. And, for the cherry on top, we get evidence of performance against asymptomatic infection! Dr. Jarvis does a quick review of the latest evidence on vaccine performance.
By Long Pause Media | FlightBridgeED4.9
126126 ratings
We saw the amazing performance of Pfizer and Moderna's two mRNA COVID vaccines in their RCTs. As encouraging as trial performance is, we always want to know how those numbers hold up under large-scale, real-world pragmatic conditions. Well, we now have three new pieces of information on that. And, for the cherry on top, we get evidence of performance against asymptomatic infection! Dr. Jarvis does a quick review of the latest evidence on vaccine performance.

1,868 Listeners

544 Listeners

260 Listeners

384 Listeners

97 Listeners

804 Listeners

223 Listeners

259 Listeners

263 Listeners

274 Listeners

704 Listeners

249 Listeners

870 Listeners

231 Listeners

196 Listeners